Division of Clinical Research

Office of the Vice President and Innovation

On Wednesday, September 2, 2020, from 12:15 pm – 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2.


Date: September 2, 2020

Time: 12:15 p.m. – 1:15 p.m.
There is significant interest in this Town Hall.  Connecting early is highly recommended.To ensure you are connected, please dial-in at 12:00 p.m. 

U.S. Callers Dial:

  • 888-455-1392
  • Conference Number: RWXW1646987
  • Passcode: 9493939

International Callers Dial:

  • 1-773-799-3847
  • Conference Number: RWXW1646987
  • Passcode: 9493939

Participants can also join the event directly at: https://www.mymeetings.com/nc/join.php?i=RWXW1646987&p=9493939&t=c

To view Town Hall details: https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-09022020?utm_campaign=2020-08-31%20September%202%20Virtual%20Town%20Hall&utm_medium=email&utm_source=Eloqua

Categories COVID-19
Tagged ,

Follow this blog